Search PDMR transactions

Notifier
Name of person with notification obligation
Chenjie Xu
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Christer Fåhraeus
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
EQL Pharma AB
Issuer´s LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share EQL Pharma SE0005497732 Acquisition 5,000 Quantity 26.95 SEK 17/06/2022 SPOTLIGHT STOCK MARKET
Share EQL Pharma SE0005497732 Acquisition 1,438 Quantity 27.00 SEK 17/06/2022 SPOTLIGHT STOCK MARKET
Share EQL Pharma SE0005497732 Acquisition 1,852 Quantity 27.00 SEK 20/06/2022 SPOTLIGHT STOCK MARKET
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EQL Pharma SE0005497732 Acquisition 17/06/2022 SPOTLIGHT STOCK MARKET 6,438 (Quantity) 26.96116806 SEK
EQL Pharma SE0005497732 Acquisition 20/06/2022 SPOTLIGHT STOCK MARKET 1,852 (Quantity) 27.00 SEK
<< Back